CTC Detection Rate in SCCHN With a in Vivo Device
Enumeration and Molecular Characterization of Circulating Tumor Cells (CTCs) Using a in Vivo Device in Squamous Cell Carcinoma of Head and Neck (SCCHN)
1 other identifier
interventional
50
1 country
1
Brief Summary
Detection rate and isolation yield of CTC is low in squamous cell carcinoma of head and neck (SCCHN) with in vitro approaches rely on limited sample volumes. In this study, we applied a new method, the CellCollector, which could capture CTC in vivo from peripheral blood.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2016
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 22, 2016
CompletedFirst Submitted
Initial submission to the registry
March 1, 2017
CompletedFirst Posted
Study publicly available on registry
March 7, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 20, 2017
CompletedMarch 7, 2017
March 1, 2017
9 months
March 1, 2017
March 1, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
CTC isolation
Isolate circulating tumor cells in vivo with CellCollector
9 month
Study Arms (2)
SCCHN
EXPERIMENTALsquamous cell carcinoma of the head and neck
Control
EXPERIMENTALhealth volunteers
Interventions
Detect circulating tumor cells with CellCollector in SCCHN and control group.
Eligibility Criteria
You may qualify if:
- SCCHN confirmed with clinical examination
- Have agreed to undergo CTC analysis in vivo;
- ECOG：0-2
You may not qualify if:
- the other cancer types
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nanjing Tongren Hospital
Nanjing, Jiangsu, 211102, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 1, 2017
First Posted
March 7, 2017
Study Start
June 22, 2016
Primary Completion
March 15, 2017
Study Completion
April 20, 2017
Last Updated
March 7, 2017
Record last verified: 2017-03